Can Psychotherapy Reduce Sickness Absence?

Sponsor
Lovisenberg Diakonale Hospital (Other)
Overall Status
Active, not recruiting
CT.gov ID
NCT01181635
Collaborator
(none)
400
1
1
148
2.7

Study Details

Study Description

Brief Summary

The purpose of this study is to examine if psychotherapy can reduce sickness absence.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Psychotherapy
N/A

Detailed Description

Sickness absence due to psychiatric problems is considered a growing problem in Norway. Little research is done to examine if psychotherapy can reduce sickness absence. Since 2007 there is a government sponsored program in Norway (Raskere tilbake) aimed at reducing sickness absence. This study examines if psychotherapy within this program, delivered at an out-patient clinic, actually reduces sickness absence. Levels of absenteeism is measured before, after and 6 months after treatment. This is a quasi-experimental study, where the treatment-group will be compared with a statistical group in the general population, that is socio-demographical similar and has similar history of sickness absence but haven't been to treatment. Changes in levels of symptoms and quality of life will also be measured. The participants will be asked to describe their working environment, and this will be related to outcome-measures.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
400 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Can Psychotherapy Reduce Sickness Absence?
Study Start Date :
Aug 1, 2010
Anticipated Primary Completion Date :
Dec 1, 2019
Anticipated Study Completion Date :
Dec 1, 2022

Arms and Interventions

Arm Intervention/Treatment
Experimental: Psychotherapy

Short-term pychotherapy and/or psychoeduchative courses.

Behavioral: Psychotherapy
Standard psychotherapy for psychiatric disorders.

Outcome Measures

Primary Outcome Measures

  1. Sickness absence [Before, after and 6 months after treatment.]

    Present status (working or sick).

Secondary Outcome Measures

  1. Psychiatric symptoms [Before, after and 6 months after treatment.]

    CORE-OM.

  2. Quality of life (QALY) [Before, after and 6 months after treatment.]

    15 D

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Patients receiving psychotherapy at Lovisenberg DPS/Raskere Tilbake
Exclusion Criteria:

Contacts and Locations

Locations

Site City State Country Postal Code
1 Lovisenberg diakonale sykehus, Lovisenberg DPS Oslo Norway 0440

Sponsors and Collaborators

  • Lovisenberg Diakonale Hospital

Investigators

  • Study Director: Bjørn Lau, phd, Lovisenberg Diakonale Hospital

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Lovisenberg Diakonale Hospital
ClinicalTrials.gov Identifier:
NCT01181635
Other Study ID Numbers:
  • 2010/494 (REK)
First Posted:
Aug 13, 2010
Last Update Posted:
Aug 9, 2019
Last Verified:
Apr 1, 2016
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Aug 9, 2019